2 Oct 2018 12:57
Consort Medical plc
Savings Related Share Option Award
Consort Medical plc announces that on 1 October 2018 the following PDMRs were granted options over ordinary shares of 10p each in the Company pursuant to the Consort Medical Sharesave Plan 2017. The options were granted with an exercise price of £12.04.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Jonathan Glenn
| |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10p each | |||
Identification code | GB0000946276 | ||||
b)
| Nature of the transaction
| Option to purchase shares granted under the Consort Medical Sharesave Plan 2017 exercisable three years from the savings contract start date provided that the required monthly savings are made. | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£12.04 | 747 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 747 | ||||
- Price | £8,993.88 | ||||
e)
| Date of the transaction
| 2018.10.01 | |||
f)
| Place of the transaction
| Outside of a trading venue | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Paul Hayes | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CFO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10p each | |||
Identification code | GB0000946276 | ||||
b)
| Nature of the transaction
| Option to purchase shares granted under the Consort Medical Sharesave Plan 2017 exercisable three years from the savings contract start date provided that the required monthly savings are made. | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£12.04 | 1,495 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 1,495 | ||||
- Price | £17,999.80 | ||||
e)
| Date of the transaction
| 2018.10.01 | |||
f)
| Place of the transaction
| Outside of a trading venue | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Keyvan Djamarani | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Bespak | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10p each | |||
Identification code | GB0000946276 | ||||
b)
| Nature of the transaction
| Option to purchase shares granted under the Consort Medical Sharesave Plan 2017 exercisable three years from the savings contract start date provided that the required monthly savings are made. | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£12.04 | 1,495 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 1,495 | ||||
- Price | £17,999.80 | ||||
e)
| Date of the transaction
| 2018.10.01 | |||
f)
| Place of the transaction
| Outside of a trading venue | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
| Manja Boerman | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Managing Director Aesica | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 10p each | |||
Identification code | GB0000946276 | ||||
b)
| Nature of the transaction
| Option to purchase shares granted under the Consort Medical Sharesave Plan 2017 exercisable three years from the savings contract start date provided that the required monthly savings are made. | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£12.04 | 1,495 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 1,495 | ||||
- Price | £17,999.80 | ||||
e)
| Date of the transaction
| 2018.10.01 | |||
f)
| Place of the transaction
| Outside of a trading venue | |||